Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Detection of Epstein-Barr Virus Related Disease. Improving Quantification of EBV in Blood Samples Using Polymerase Chain Reaction.

NCT03546101 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT03546101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03546101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Detection of Epstein-Barr Virus Related Disease. Improving Quantification of EBV in Blood Samples Using Polymerase Chain Reaction.
Lead sponsor
University of Aarhus
Phase
Observational
Overall status
Completed
Start date
November 1, 2017
Completion date
May 1, 2023
Enrollment
1,527 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epstein-barr viraemia, epstein-barr virus infections, epstein-barr virus related malignancy, epstein-barr virus-related hodgkin lymphoma, epstein-barr virus-related non-hodgkin lymphoma, hemophagocytic lymphohistiocytoses, hemophagocytosis, mononucleosis, post-transplant lymphoproliferative disorder